AMBAR, an Encouraging Alzheimer's Trial That Raises Questions
Author:
Funder
Beaumont Health System
Publisher
Frontiers Media SA
Subject
Clinical Neurology,Neurology
Reference104 articles.
1. Amyloid deposition as the central event in the aetiology of alzheimer's disease;Hardy;Trends Pharmacol Sci,1991
2. Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial;Gilman;Neurology,2005
3. Phase 3 trials of solanezumab for mild-to-moderate alzheimer's disease;Doody;N Engl J Med,2014
4. The antibody aducanumab reduces Aβ plaques in alzheimer's disease;Sevigny;Nature,2016
5. A phase III randomized trial of gantenerumab in prodromal alzheimer's disease;Ostrowitzki;Alzheimers Res Ther,2017
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular dynamics of amyloid-β transport in Alzheimer's disease: Exploring therapeutic plasma exchange with albumin replacement – Current insights and future perspectives;Neurología;2024-08
2. Blood-based therapies to combat neurodegenerative diseases;Metabolic Brain Disease;2024-06-06
3. Role of Human Serum Albumin in the Prevention and Treatment of Alzheimer’s Disease;Biology Bulletin Reviews;2024-02
4. Toward Prevention and Reduction of Alzheimer’s Disease;Journal of Alzheimer's Disease;2023-11-07
5. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue;Journal of Clinical Apheresis;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3